Features of the bronchial bacterial microbiome associated with atopy, asthma and responsiveness to inhaled corticosteroid treatment
It’s been known that asthmatic lungs are different from healthy lungs in many aspects, including housing different strains of bacteria. So far, studies haven’t been able to tell whether these differences are due to asthma, associated allergies (atopy), or treatment with different drugs. They also haven’t been able to determine how these differences affect the way asthma manifests itself and how asthma can be treated. In this month’s issue of JACI, Durack and colleagues aim to answer these pressing questions ( J Allergy Clin Immunol 2017; 140(1): 63-75 ). Durack and other investigators looked at the bacterial communities in 84 individuals, split into three groups: (1) 42 atopic asthmatic subjects, (2) 21 atopic non-asthmatic subjects, and (3) 21 non-atopic non-asthmatic, otherwise healthy, subjects. They also looked at inflammatory markers and changes in bronchial hyperresponsiveness after 6 weeks of treatment with fluticasone, an inhaled steroid commonly used for...